- Screen with NEWS2, MEWS or SIRS — not qSOFA alone (SSC 2026).
- Shock or probable sepsis → cultures, then antibiotics within 1 hour. Possible sepsis without shock → rapid workup, antibiotics within 3 hours if infection still likely.
- Hypoperfusion → ≥30 mL/kg balanced crystalloid in the first 3 hours (ideal/adjusted weight if BMI >30). Guide more fluid with dynamic tests.
- Norepinephrine for MAP ≥65 (60–65 if age ≥65). Peripheral start is OK.
- Still on pressors → hydrocortisone 200 mg/day.
- Find and control the source. De-escalate as soon as cultures return.
Pathophysiology in 60 seconds
⌄
- Sepsis-3: life-threatening organ dysfunction (SOFA rise ≥2) from a dysregulated host response to infection.
- Septic shock: sepsis + vasopressors for MAP ≥65 + lactate >2 despite fluids.
- Vasodilation (NO), capillary leak, myocardial depression and microcirculatory failure → tissues starve even with "OK" BP.
- Lactate rises from β₂-adrenergic glycolysis as much as from hypoxia — still a strong risk marker.
- 0 min
Recognize: NEWS2 / MEWS / SIRS (not qSOFA alone)
- ≤ 1 h
Blood cultures ×2 →
antibiotics (shock or probable sepsis)
- ≤ 1 h
Lactate; repeat if >2
- ≤ 3 h
≥30 mL/kg balanced crystalloid if hypoperfused (ideal/adjusted weight if BMI >30)
- Early
Norepinephrine to MAP ≥65 (60–65 if age ≥65) — peripheral OK to start
- Ongoing
Source control · reassess with dynamic tests (PLR, CRT) · steroids if still on pressors
- Screening: NEWS/NEWS2/MEWS/SIRS over qSOFA (strong).
- Balanced crystalloids over saline; crystalloids alone over adding albumin (albumin reasonable after large volumes or in cirrhosis).
- Prolonged-infusion β-lactams after the loading dose (strong).
- De-escalation once susceptibilities return (strong).
- No routine anaerobic coverage unless risk factors (abdominal/pelvic source, necrotizing infection, head–neck, CNS abscess).
- MAP >65 initial target; 60–65 in age ≥65. Non-invasive BP acceptable at low pressor doses.
- After resuscitation, active fluid removal is suggested.
Diagnosis & workup
⌄
- Two sets of blood cultures before antibiotics (do not delay abx >45 min for them).
- Lactate (repeat in 2–4 h if >2), CBC, BMP, LFTs, coags, UA/urine culture, CXR, procalcitonin (helps stopping, not starting).
- Source imaging: CT abdomen, ultrasound RUQ/kidneys, line/skin check.
- POCUS: IVC, LV/RV function, B-lines, free fluid.
Management
⌄
| Situation | Empiric choice (adjust to local antibiogram) |
|---|---|
| Unknown source, community | Ceftriaxone ± vancomycin (MRSA risk) |
| Hospital-acquired / healthcare risk | Cefepime or pip-tazo + vancomycin |
| Prior ESBL / recent carbapenem-sensitive only | Meropenem |
| Abdominal source | Pip-tazo (or ceftriaxone + metronidazole) |
| Neutropenic | Cefepime / pip-tazo / meropenem (+ vanc if indicated) |
| Toxic shock / necrotizing | Add clindamycin (or linezolid) for toxin suppression |
Narrow within 48–72 h. Typical duration 7 days for most sources with good source control.
- 30 mL/kg balanced crystalloid (LR / Plasma-Lyte) in 3 h when hypoperfused.
- Then fluid only if responsive: passive leg raise, pulse-pressure variation, cap refill time.
- Norepinephrine first (0.05–0.5 mcg/kg/min).
- Add vasopressin 0.03 U/min when NE ~0.25 mcg/kg/min.
- Add epinephrine if MAP still low. Dobutamine if low cardiac output.
- Arterial line if pressor needs are rising or multiple agents.
- Hydrocortisone 50 mg IV q6h (± fludrocortisone 50 mcg daily) for ongoing pressor need. Stop when off pressors.
- Glucose 140–180.
- VTE and stress-ulcer prophylaxis (if risk factors).
- Transfuse at Hb <7.
- No vitamin C. Bicarbonate only if pH ≤7.2 with AKI.
Pitfalls
⌄
- Waiting for the lactate or CT before antibiotics in shock.
- 6 L of fluid with no reassessment → edema, ARDS, AKI.
- "Pan-cultures" without looking for a drainable source.
- Staying broad after cultures return.
- Rate-controlling compensatory tachycardia (AF in sepsis).
Board corner
⌄
| Stem | Answer |
|---|---|
| Septic shock, MAP 58 after 30 mL/kg | Norepinephrine |
| On NE 0.3 mcg/kg/min | Add vasopressin |
| Still on 2 pressors | Hydrocortisone |
| Septic shock + cholangitis | Antibiotics + urgent ERCP (source control) |
| Toxic shock syndrome | β-lactam + clindamycin, remove tampon/foreign body |
References
⌄
- Prescott HC, Antonelli M, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026. Crit Care Med. 2026.
- Singer M, et al. Sepsis-3. JAMA. 2016;315:801.
- BaSICS · SMART · CLOVERS · APROCCHSS · ADRENAL · BLING III.